Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene.
Magnetic Resonance Spectroscopy: A Possible In Vivo Marker of Disease Progression for Multiple Sclerosis?
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality.
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases.
Three-dimensional geometries representing the retinal nerve fiber layer in multiple sclerosis, optic neuritis, and healthy eyes.
[Consensus document on spasticity in patients with multiple sclerosis.]
Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
Natalizumab (BG00002) Re-Initiation of Dosing. (STRATA)
Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis.
The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.
Multiple sclerosis: Repurposing dopaminergic drugs for MS - the evidence mounts.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
[Changes of epidemiological and clinical features and disease concept in multiple sclerosis].
Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage.
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
Optic neuritis in neuromyelitis optica.
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
Treatment of Neuromyelitis Optica: Review and Recommendations.
Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident optic neuritis.
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging.
Pages
« first
‹ previous
…
316
317
318
319
320
321
322
323
324
…
next ›
last »